Annual CAPEX
$1.03 M
-$89.70 K-7.98%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual capital expenditures is $1.03 million, with the most recent change of -$89.70 thousand (-7.98%) on April 30, 2024.
- During the last 3 years, IPA annual CAPEX has fallen by -$56.00 thousand (-5.14%).
- IPA annual CAPEX is now -35.68% below its all-time high of $1.61 million, reached on December 31, 2006.
Performance
IPA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$48.20 K
-$143.80 K-74.90%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly capital expenditures is $48.20 thousand, with the most recent change of -$143.80 thousand (-74.90%) on October 31, 2024.
- Over the past year, IPA quarterly CAPEX has dropped by -$143.80 thousand (-74.90%).
- IPA quarterly CAPEX is now -96.80% below its all-time high of $1.51 million, reached on March 31, 2005.
Performance
IPA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$954.50 K
-$170.20 K-15.13%
October 31, 2024
Summary
- As of February 8, 2025, IPA TTM capital expenditures is $954.50 thousand, with the most recent change of -$170.20 thousand (-15.13%) on October 31, 2024.
- Over the past year, IPA TTM CAPEX has dropped by -$170.20 thousand (-15.13%).
- IPA TTM CAPEX is now -52.26% below its all-time high of $2.00 million, reached on March 31, 2005.
Performance
IPA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
IPA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.0% | -74.9% | -15.1% |
| 3 y3 years | -5.1% | -74.9% | -15.1% |
| 5 y5 years | +111.3% | -74.9% | -15.1% |
IPA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.0% | +3.3% | -94.2% | +140.1% | -22.7% | +71.0% |
| 5 y | 5-year | -8.0% | +139.8% | -94.2% | +140.1% | -29.0% | +142.6% |
| alltime | all time | -35.7% | >+9999.0% | -96.8% | +104.8% | -52.3% | >+9999.0% |
ImmunoPrecise Antibodies CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | $48.20 K(-74.9%) | $954.50 K(-15.1%) |
| Jul 2024 | - | $192.00 K(-77.0%) | $1.12 M(+8.7%) |
| Apr 2024 | $1.03 M(-8.0%) | $834.60 K(-793.8%) | $1.03 M(+85.4%) |
| Jan 2024 | - | -$120.30 K(-155.1%) | $558.10 K(-34.5%) |
| Oct 2023 | - | $218.40 K(+114.5%) | $852.40 K(-26.3%) |
| Jul 2023 | - | $101.80 K(-71.6%) | $1.16 M(+2.9%) |
| Apr 2023 | $1.12 M(+12.2%) | $358.20 K(+105.9%) | $1.12 M(+26.6%) |
| Jan 2023 | - | $174.00 K(-66.7%) | $887.90 K(-28.1%) |
| Oct 2022 | - | $522.90 K(+656.7%) | $1.24 M(+55.5%) |
| Jul 2022 | - | $69.10 K(-43.3%) | $794.20 K(-20.7%) |
| Apr 2022 | $1.00 M(-8.1%) | $121.90 K(-76.6%) | $1.00 M(-8.9%) |
| Jan 2022 | - | $521.30 K(+536.5%) | $1.10 M(+24.4%) |
| Oct 2021 | - | $81.90 K(-70.4%) | $884.20 K(-34.2%) |
| Jul 2021 | - | $276.70 K(+25.6%) | $1.34 M(+23.2%) |
| Apr 2021 | $1.09 M(+152.7%) | $220.30 K(-27.8%) | $1.09 M(+22.1%) |
| Jan 2021 | - | $305.30 K(-43.6%) | $893.00 K(+11.8%) |
| Oct 2020 | - | $541.50 K(+2214.1%) | $798.60 K(+102.9%) |
| Jul 2020 | - | $23.40 K(+2.6%) | $393.50 K(-8.8%) |
| Apr 2020 | $431.50 K(-11.8%) | $22.80 K(-89.2%) | $431.50 K(-12.1%) |
| Jan 2020 | - | $210.90 K(+54.6%) | $490.70 K(+31.5%) |
| Oct 2019 | - | $136.40 K(+122.1%) | $373.10 K(-29.9%) |
| Jul 2019 | - | $61.40 K(-25.1%) | $532.50 K(+8.8%) |
| Apr 2019 | $489.50 K(+80.8%) | $82.00 K(-12.1%) | $489.60 K(+3.1%) |
| Jan 2019 | - | $93.30 K(-68.5%) | $475.10 K(+4.7%) |
| Oct 2018 | - | $295.80 K(+1498.9%) | $453.60 K(+186.4%) |
| Jul 2018 | - | $18.50 K(-72.6%) | $158.40 K(-41.5%) |
| Apr 2018 | $270.80 K(-32.8%) | $67.50 K(-6.0%) | $270.70 K(+33.2%) |
| Jan 2018 | - | $71.80 K(>+9900.0%) | $203.20 K(+54.6%) |
| Oct 2017 | - | $600.00(-99.5%) | $131.40 K(+0.5%) |
| Jul 2017 | - | $130.80 K(>+9900.0%) | $130.80 K(+7594.1%) |
| Apr 2017 | $402.90 K(>+9900.0%) | - | - |
| Dec 2011 | $1700.00(-87.1%) | - | - |
| Dec 2011 | - | $0.00(-100.0%) | $1700.00(-148.6%) |
| Sep 2011 | - | $1700.00(-132.7%) | -$3500.00(-126.5%) |
| Dec 2010 | $13.20 K(-95.5%) | - | - |
| Dec 2010 | - | -$5200.00(-128.6%) | $13.20 K(+29.4%) |
| Sep 2010 | - | $18.20 K(>+9900.0%) | $10.20 K(-37.0%) |
| Jun 2010 | - | $0.00(-100.0%) | $16.20 K(-77.7%) |
| Mar 2010 | - | $200.00(-102.4%) | $72.80 K(-75.2%) |
| Dec 2009 | $293.80 K(-77.5%) | - | - |
| Dec 2009 | - | -$8200.00(-133.9%) | $293.80 K(-47.7%) |
| Sep 2009 | - | $24.20 K(-57.2%) | $561.60 K(-63.1%) |
| Jun 2009 | - | $56.60 K(-74.4%) | $1.52 M(+0.1%) |
| Mar 2009 | - | $221.20 K(-14.8%) | $1.52 M(+16.1%) |
| Dec 2008 | $1.31 M(+1232.4%) | - | - |
| Dec 2008 | - | $259.60 K(-73.6%) | $1.31 M(+14.1%) |
| Sep 2008 | - | $982.80 K(+1686.9%) | $1.15 M(+598.9%) |
| Jun 2008 | - | $55.00 K(+404.6%) | $164.10 K(+66.1%) |
| Mar 2008 | - | $10.90 K(-88.9%) | $98.80 K(+0.6%) |
| Dec 2007 | $98.20 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | - | $98.20 K(-1053.4%) | $98.20 K(-91.8%) |
| Jun 2007 | - | -$10.30 K(-200.0%) | $1.20 M(-22.5%) |
| Mar 2007 | - | $10.30 K(-93.6%) | $1.55 M(-3.9%) |
| Dec 2006 | $1.61 M(+5.4%) | - | - |
| Dec 2006 | - | $160.90 K(-84.5%) | $1.61 M(-5.9%) |
| Sep 2006 | - | $1.04 M(+206.7%) | $1.71 M(+19.6%) |
| Jun 2006 | - | $338.10 K(+366.3%) | $1.43 M(+1474.6%) |
| Mar 2006 | - | $72.50 K(-72.4%) | $90.80 K(-94.0%) |
| Dec 2005 | $1.53 M(+130.5%) | - | - |
| Dec 2005 | - | $262.40 K(-65.3%) | $1.53 M(+11.2%) |
| Sep 2005 | - | $756.70 K(-175.6%) | $1.37 M(+41.6%) |
| Jun 2005 | - | -$1.00 M(-166.4%) | $968.60 K(-51.6%) |
| Mar 2005 | - | $1.51 M(+1286.5%) | $2.00 M(+202.1%) |
| Dec 2004 | $661.90 K(+260.7%) | - | - |
| Dec 2004 | - | $108.70 K(-69.3%) | $661.90 K(+10.7%) |
| Sep 2004 | - | $353.60 K(+1074.8%) | $598.10 K(+66.3%) |
| Jun 2004 | - | $30.10 K(-82.2%) | $359.70 K(+2.2%) |
| Mar 2004 | - | $169.50 K(+277.5%) | $351.80 K(+91.7%) |
| Dec 2003 | $183.50 K(+92.8%) | - | - |
| Dec 2003 | - | $44.90 K(-61.0%) | $183.50 K(+33.6%) |
| Sep 2003 | - | $115.20 K(+418.9%) | $137.30 K(+515.7%) |
| Jun 2003 | - | $22.20 K(+1750.0%) | $22.30 K(+757.7%) |
| Mar 2003 | - | $1200.00(-192.3%) | $2600.00(-97.3%) |
| Dec 2002 | $95.20 K(+1570.2%) | - | - |
| Dec 2002 | - | -$1300.00(-750.0%) | $95.20 K(-1.3%) |
| Sep 2002 | - | $200.00(-92.0%) | $96.50 K(+0.2%) |
| Jun 2002 | - | $2500.00(-97.3%) | $96.30 K(+2.7%) |
| Mar 2002 | - | $93.80 K(-76.9%) | $93.80 K(-80.1%) |
| Dec 2001 | $5700.00(-98.8%) | - | - |
| Dec 2000 | $471.70 K(+354.4%) | - | - |
| Dec 2000 | - | $405.40 K(+581.3%) | $471.70 K(+460.9%) |
| Sep 2000 | - | $59.50 K(<-9900.0%) | $84.10 K(+70.2%) |
| Jun 2000 | - | -$100.00(-101.4%) | $49.40 K(-29.9%) |
| Mar 2000 | - | $6900.00(-61.2%) | $70.50 K(-32.1%) |
| Dec 1999 | $103.80 K(-58.1%) | - | - |
| Dec 1999 | - | $17.80 K(-28.2%) | $103.80 K(-56.6%) |
| Sep 1999 | - | $24.80 K(+18.1%) | $239.10 K(+1.4%) |
| Jun 1999 | - | $21.00 K(-47.8%) | $235.70 K(-3.5%) |
| Mar 1999 | - | $40.20 K(-73.7%) | $244.30 K(-1.5%) |
| Dec 1998 | $247.90 K(-68.2%) | - | - |
| Dec 1998 | - | $153.10 K(+615.4%) | $247.90 K(+40.3%) |
| Sep 1998 | - | $21.40 K(-27.7%) | $176.70 K(-60.7%) |
| Jun 1998 | - | $29.60 K(-32.4%) | $449.90 K(-38.1%) |
| Mar 1998 | - | $43.80 K(-46.5%) | $726.90 K(-6.8%) |
| Dec 1997 | $780.00 K(+104.6%) | - | - |
| Dec 1997 | - | $81.90 K(-72.2%) | $780.10 K(+11.7%) |
| Sep 1997 | - | $294.60 K(-3.9%) | $698.20 K(+73.0%) |
| Jun 1997 | - | $306.60 K(+216.1%) | $403.60 K(+316.1%) |
| Mar 1997 | - | $97.00 K | $97.00 K |
| Dec 1996 | $381.30 K | - | - |
FAQ
- What is ImmunoPrecise Antibodies annual capital expenditures?
- What is the all time high annual CAPEX for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual CAPEX year-on-year change?
- What is ImmunoPrecise Antibodies quarterly capital expenditures?
- What is the all time high quarterly CAPEX for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly CAPEX year-on-year change?
- What is ImmunoPrecise Antibodies TTM capital expenditures?
- What is the all time high TTM CAPEX for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies TTM CAPEX year-on-year change?
What is ImmunoPrecise Antibodies annual capital expenditures?
The current annual CAPEX of IPA is $1.03 M
What is the all time high annual CAPEX for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual capital expenditures is $1.61 M
What is ImmunoPrecise Antibodies annual CAPEX year-on-year change?
Over the past year, IPA annual capital expenditures has changed by -$89.70 K (-7.98%)
What is ImmunoPrecise Antibodies quarterly capital expenditures?
The current quarterly CAPEX of IPA is $48.20 K
What is the all time high quarterly CAPEX for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly capital expenditures is $1.51 M
What is ImmunoPrecise Antibodies quarterly CAPEX year-on-year change?
Over the past year, IPA quarterly capital expenditures has changed by -$143.80 K (-74.90%)
What is ImmunoPrecise Antibodies TTM capital expenditures?
The current TTM CAPEX of IPA is $954.50 K
What is the all time high TTM CAPEX for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high TTM capital expenditures is $2.00 M
What is ImmunoPrecise Antibodies TTM CAPEX year-on-year change?
Over the past year, IPA TTM capital expenditures has changed by -$170.20 K (-15.13%)